IL-6 for example, has been suggested to activate the JAK/STAT pathway and also upregulate the expression of programmed cell death ligand-1 (PD-L1), thereby conferring immunosuppression in the microenvironment of NKTCL [70]. Here, CD274 is linked to extranodal nasal NK/T cell lymphoma.